1. Volume 67, Issue 1, Pages 64-70 (January 2015)
Dissecting the Association Between Metabolic Syndrome and Prostate Cancer Risk: Analysis of a Large Clinical Cohort 
Bimal Bhindi, Jennifer Locke, Shabbir M.H. Alibhai, Girish S. Kulkarni, David S. Margel, Robert J. Hamilton, Antonio Finelli, John Trachtenberg, Alexandre R. Zlotta, Ants Toi, Karen M. Hersey, Andrew Evans, Theodorus H. van der Kwast, Neil E. Fleshner 
European Urology 
Volume 67, Issue 1, Pages (January 2015)
DOI: /j.eururo
Copyright © 2014 European Association of Urology Terms and Conditions

2. Fig. 1
Biologic gradient that exists between the number of metabolic syndrome components and the odds of prostate cancer (PCa), clinically significant PCa, and intermediate- or high-grade disease.
CSPC=clinically significant prostate cancer; I-HGPC=intermediate- or high-grade prostate cancer; ref.=reference value.
European Urology  , 64-70DOI: ( /j.eururo )
Copyright © 2014 European Association of Urology Terms and Conditions